Real-World Evidence of the Long-Term Effectiveness of 0.2 μg/Day Fluocinolone Acetonide Implant in Persistent and Recurrent Diabetic Macular Edema – A Single Center Study-Reference-Cited by-同舟云学术

Real-World Evidence of the Long-Term Effectiveness of 0.2 μg/Day Fluocinolone Acetonide Implant in Persistent and Recurrent Diabetic Macular Edema – A Single Center Study

Published:2024-04 Issue: Volume:Volume 18 Page:1057-1066
ISSN:1177-5483
Container-title:Clinical Ophthalmology
language:en
Short-container-title:OPTH

Author:

Soares Ricardo^ORCID,Ferreira Catarina^ORCID,Fernandes Joana,Madeira Carolina,Silva Luís,Saraiva Eduardo,Ribeiro Lígia,Fonseca Sofia

Publisher

Informa UK Limited

Reference32 articles.

1. Current Epidemiology of Diabetic Retinopathy and Diabetic Macular Edema

Clinical-Decision Criteria to Identify Recurrent Diabetic Macular Edema Patients Suitable for Fluocinolone Acetonide Implant Therapy (ILUVIEN^®) and Follow-Up Considerations/Recommendations

Real-world retrospective comparison of 0.19 mg fluocinolone acetonide and 0.7 mg dexamethasone intravitreal implants for the treatment of diabetic macular edema in vitrectomized eyes

4. Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment

5. A New Approach for Diabetic Macular Edema Treatment: Review of Clinical Practice Results with 0.19 mg Fluocinolone Acetonide Intravitreal Implant Including Vitrectomized Eyes

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of dexamethasone implants in treating diabetic macular edema with hard exudates: a clinical observation;International Ophthalmology;2024-09-10

2. Effectiveness of Dexamethasone Implants in Treating Diabetic Macular Edema with Hard Exudates: A Clinical Observation;2024-05-14